Worth the Wait Neoadjuvant therapy—using treatments such as chemotherapy, hormone therapy or radiation to shrink a tumor or treat unseen metastases before surgery—can improve outcomes for some patients. by Sharon Tregaskis Our Own Words People with cancer and their loved ones find ways for their voices to be heard without filters. by Bradley Jones Survivor Profile Still in the Game ESPN reporter Holly Rowe worked through melanoma treatment. by Lindsey Konkel Q&A Dissecting Mental Illness Neuroscientist Barbara Lipska describes her experiences with symptoms of psychiatric illness caused by treatment for metastases in her brain. by Marci A. Landsmann Pembrolizumab Shows Further Promise for Melanoma In a phase III clinical trial, pembrolizumab yielded a 75.4 percent recurrence-free survival rate after 12 months among patients whose stage III melanoma tumors had been fully resected. by Brad Jones Forward Look Tackling Drug Resistance Researchers are studing new ways to keep treatments working longer. by Stephen Ornes Survivor Profile Living in the Here and Now A metastatic melanoma survivor is hopeful but realistic as new treatments become available. by Jenny Song Forward Look Cancer Immunotherapies Continue to Make Headway Drugs that harness the power of the immune system gain new approvals. by Alexandra Goho Survivor Profile Knowing Her Options When Christina McEvoy was diagnosed with stage IV melanoma, she took the reins of her care, traveling more than 600 miles for treatment and returning home to help other melanoma survivors. by Melissa Davlin First Person Keeping Sight of Hope A survivor keeps an eye on what's ahead after a rare cancer diagnosis. by Sue Russell next Cancer Talk Coverage of the AACR Annual Meeting 2021 This year’s AACR Annual Meeting features the latest advances in basic, translational and clinical cancer research. The more than 13,000 attendees at the virtual event represent more than 70 countries. by Kevin McLaughlin Searching the Blood for Signs of Altered Immunity The immune systems of people with blood cancer respond differently to infection with the coronavirus than the immune systems of people without cancer or with solid tumors. by Kate Yandell Immunotherapy Indications Withdrawn In recent months, drugmakers have announced they are withdrawing indications for four immune checkpoint inhibitors in consultation with the Food and Drug Administration. What does this mean for patients who are taking these drugs? by Anna Goshua Cancer Did Not Cancel Our Plans After her husband’s diagnosis with metastatic cancer, Miriam Díaz-Gilbert made it her goal to keep him moving. by Miriam Díaz-Gilbert More Posts